TM vs TSV Implants Loaded Early vs Conventional in Anterior and Posterior Areas

NCT ID: NCT02158377

Last Updated: 2022-03-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

120 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-03-31

Study Completion Date

2020-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Randomized-controlled, multicenter study of Trabecular Metal (TM) and Tapered Screw-Vent (TSV) dental implants loaded early in maxillary and mandibular sites.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a randomized, controlled, multicenter study to assess and compare implant stability of Trabecular Metal (TM) dental implants and Tapered Screw-Vent (TSV) implants during the early stages of healing i.e. 21 +/- 2 days and 42+/- 2 days, as well as their short term clinical outcomes.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Partial Edentulism Tooth Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Tapered Screw-vent implants (TSV)

TSV implants to replace missing tooth/teeth

Group Type ACTIVE_COMPARATOR

Tapered screw-vent implants (TSV)

Intervention Type DEVICE

Patients receive TSV dental implants in this arm. The early stability is measured and compared to the stability of the TM implants. The implants are loaded and provisionalized early at 3 or 6 weeks if stability permits.

Trabecular Metal dental implants (TM)

TM dental implants to replace missing tooth/teeth

Group Type EXPERIMENTAL

Trabecular metal dental implants (TM)

Intervention Type DEVICE

Patients receive TM dental implants in this arm. The early stability is measured and compared to the stability of the TSV implants. The implants are loaded and provisionalized early at 3 or 6 weeks if stability permits.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Trabecular metal dental implants (TM)

Patients receive TM dental implants in this arm. The early stability is measured and compared to the stability of the TSV implants. The implants are loaded and provisionalized early at 3 or 6 weeks if stability permits.

Intervention Type DEVICE

Tapered screw-vent implants (TSV)

Patients receive TSV dental implants in this arm. The early stability is measured and compared to the stability of the TM implants. The implants are loaded and provisionalized early at 3 or 6 weeks if stability permits.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Benefit from the implant and restoration
2. Provide a voluntarily signed Informed Consent
3. Must be 18 years or older
4. Have one or more edentulous area(s) in the posterior maxilla or mandible designated for an implant supported restoration
5. The implantation site must have a functional antagonist to obtain full occlusion.
6. Implants adjacent to planned site of implantation should have been in function for at least 1 year.
7. The site intended for implant placement should have healed for at least 4 months from the time of extraction or at least 6 months from any other bone augmentation procedures.
8. The site intended for implant placement should have adequate bone volume to support an implant without the need for augmentation except for minor dehiscence (limited to a vertical height of 2mm), which can be augmented with autogenous bone chips to improve soft tissue attachment.
9. The site intended for implant placement should have residual facial and palatal/lingual plates to be at least 1.0mm thick after implant placement.
10. The site intended for implant placement should have vertical bone volume to extend at least 2.0mm apical to the implant after implant placement.

Exclusion Criteria

1. Subjects mentally incompetent or unable to understand and provide an Informed Consent
2. Smokers, alcoholics or drug abusers
3. Subjects with systemic conditions such as uncontrolled diabetes, endocrine disorders, heart disease, immune-compromised subjects or mental disorders
4. Use of concurrent medication which inhibits bone metabolism like bisphosphonates, corticosteroids or methotrexate
5. Bleeding disorders and/or anticoagulant therapy
6. Pregnancy
7. Known sensitivity or allergy to any of the implant materials
8. Subjects with bruxism or clenching habits
9. Uncontrolled periodontal or oral pathologies (e.g. mucosal disease, oral lesions)
10. Inadequate oral hygiene
11. History of radiation at the site intended for study implant placement
12. Subjects who have previously failed dental implants at the site intended for study implant placement
13. Subjects participating in another clinical study
14. Subjects who need other surgeries in a site adjacent to the study implant(s)
15. Subjects who need other surgeries in a site non-adjacent to the study implant(s) within 6 months of study implant placement
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

ZimVie

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Wilfried Wagner

Role: PRINCIPAL_INVESTIGATOR

Universitatsbedizin Mainz

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Universitat Regensburg

Regensburg, Bavaria, Germany

Site Status

Heinrich Heine Universitat Dusseldorf

Düsseldorf, Nordhein-Westfalen, Germany

Site Status

Universitatsmedizin Mainz

Mainz, Rhineland-Palatinate, Germany

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Germany

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CSU2011-08D

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Bone Level Tapered Multi-Center Study
NCT02569671 ACTIVE_NOT_RECRUITING NA